Abstract
Elderly patients with depression commonly suffer from concurrent symptoms of anxiety or comorbid anxiety disorders. Such comorbidity is associated with a more severe presentation of depressive illness, including greater suicidality. Additionally, most antidepressant treatment studies of elderly individuals with depression have found poorer treatment outcomes in those with comorbid anxiety, for example, delayed or diminished response and increased likelihood of dropout from treatment. In terms of treatment of anxious depression, there is evidence that tricyclic antidepressants and serotonin reuptake inhibitors are not different from each other in terms of efficacy or tolerability. Rather than the specific choice of antidepressant medication, it appears that quality of clinical management has the greatest impact on likelihood of remission in anxious depressed elderly individuals. Co-prescription of benzodiazepines is sometimes warranted for severe anxiety, but increases the risk of cognitive or motor impairment. Psychotherapy, including cognitive-behavioral therapy and interpersonal therapy, which are efficacious for late-life depression in general, should also be considered for treatment alone or in combination with appropriate medication. Future research areas are also addressed in this paper.
Similar content being viewed by others
References and Recommended Reading
Parmelee P, Katz I, Lawton MP: Anxiety and its association with depression among institutionalized elderly. Am J Geriatr Psychiatry 1993, 1:65–78.
Beekman AT, de Beurs E, van Balkom AJ, et al.: Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000, 157:89–95. Important epidemiologic study of late-life anxiety and depression comorbidity in the community.
Lenze EJ, Mulsant BH, Shear MK, et al.: Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 2000, 157:722–728. Similar study of late-life anxiety and depression comorbidity in a clinical population.
Burvill PW, Johnson GA, Jamrozik KD, et al.: Anxiety disorders after stroke: results from the Perth Community Stroke Study. Br J Psychiatry 1995, 166:328–332.
Beekman AT, Bremmer MA, Deeg DJ, et al.: Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psyciatry 1998, 13:717–726.
Flint AJ: Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994, 151:640–649.
Lyketsos CG, Steinberg M, Tschanz JT: Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry 2000, 157:708–714.
Schweizer E, Rickels K: Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand 1998, 98(suppl):95–101.
Gleason PP, Schulz R, Smith NL, et al.: Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998, 13:243–250.
Rollman BL, Block MR, Schulberg HC: Major depression and tricyclic side effects in primary care patients. J Gen Intern Med 1997, 12:284–291.
Mulsant BH, Pollock B: Treatment-resistant depression in late-life. J Geriatr Psychiatry Neurol 1998, 11:186–193.
Bartels SJ, Coakley E, Oxman TE: Suicidal and death ideation in older primary care patients with depression, anxiety, and at-risk alcohol use. Am J Geriatr Psychiatry 2002, 10:417–427.
Allgulander C, Lavori PW: Causes of death among 936 elderly patients with ‘pure’ anxiety neurosis in Stockholm County, Sweden, and in patients with depressive neurosis or both diagnoses. Compr Psychiatry 1993, 34:299–302.
Pearson JL: Recent research on suicide in the elderly. Curr Psychiatry Rep 2002, 4:59–63.
Lyness JM, Caine ED, King DA, et al.: Psychiatric disorders in older primary care patients. J Gen Intern Med 1999, 14:249–254.
Katz IR, Parmelee PA, Streim J: Depression in older patients in residential care: Significance of dysphoria. Am J Geriatr Psychiatry 1995, 3:161–169.
Karajgi B, Rifkin A, Doddi S, et al.: The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 1990, 147:200–201.
Basha I, Mukerji V, Langevin P, et al.: Atypical angina in patients with coronary artery disease suggests panic disorder. Int J Psychiatry Med 1989, 19:341–346.
Dew MA, Roth LH, Schulberg HC, et al.: Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation. Gen Hosp Psychiatry 1996, 18(suppl):48S-61S.
Lenze EJ, Rogers JC, Martire LM, et al.: The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research. Am J Geriatr Psychiatry 2001, 9:113–135.
Ormel J, Kempen GI, Deeg DJ, et al.: Functioning, well-being, and health perception in late middle-aged and older people: comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc 1998, 46:39–48.
Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55:580–592.
Moser DK, Dracup K: Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996, 58:395–401.
Watkins LL, Grossman P, Krishnan R, et al.: Anxiety reduces baroreflex cardiac control in older adults with major depression. Psychosom Med 1999, 61:334–340.
Astrom M: Generalized anxiety disorder in stroke patients: a 3-year longitudinal study. Stroke 1996, 27:270–275.
Schultz SK, Castillo CS, Kosier JT, et al.: Generalized anxiety and depression: assessment over 2 years after stroke. Am J Geriatr Psychiatry 1997, 5:229–237.
Shimoda K, Robinson RG: Effects of anxiety disorder on impairment and recovery from stroke. J Neuropsychiatry Clin Neurosci 1998, 10:34–40.
Casten RJ, Parmelee PA, Kleban MH, et al.: The relationships among anxiety, depression, and pain in a geriatric institutionalized sample. Pain 1995, 61:271–276.
Samuels S, Katz IR, Parmelee PA, et al.: Use of the Hamilton and Montgomery-Asberg Depression Scales in institutionalized elderly patients. Am J Geriatr Psychiatry 1996, 4:237–246.
Rovner BW, German PS, Brant LJ, et al.: Depression and mortality in nursing homes. JAMA 1991, 265:993–996.
Fawcett J: The detection and consequences of anxiety in clinical depression. J Clin Psychiatry 1997, 58(suppl):35–40.
Lenze EJ, Mulsant BH, Dew MA: Good treatment outcomes in late-life depression with comorbid anxiety. J Affect Disord 2003, In press.
Lenze EJ, Mulsant BH, Shear MK: Anxiety symptoms in elderly patients with depression: what is the best approach to treatment? Drugs Aging 2002, 19:753–760.
Shelton RC, Tomarken AJ: Can recovery from depression be achieved? Psychiatr Serv 2001, 52:1469–1478.
Mulsant BH, Pollock BG, Nebes R, et al.: A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry 2001, 9:406–414. One of only two randomized comparisons of an SSRI with a TCA in late-life depression.
Bondareff W, Alpert M, Friedhoff AJ, et al.: Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000, 157:729–736. The other of the two randomized comparisons of an SSRI with a TCA in late-life depression, which also evaluated secondary measures such as disability and anxiety.
Flint AJ, Rifat SL: Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry 1997, 5:107–115.
Flint AJ, Rifat SL: Two-year outcome of elderly patients with anxious depression. Psychiatry Res 1997, 66:23–31.
Meyers BS, Gabriele MS, Kakuma T, et al.: Anxiety and recurrence as predictors of recurrence in geriatric depression: a preliminary report. Am J Geriatr Psychiatry 1996, 4:252–257.
Lenze EJ, Mulsant BH, Shear MK, et al.: Comorbidity of depression and anxiety disorders in later life. Depress Anxiety 2001, 14:86–93.
Butterfield MI, Becker ME, Connor KM, et al.: Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol 2001, 16:197–203.
Mintzer J, Faison W, Street JS, et al.: Olanzapine in the treatment of anxiety symptoms due to Alzheimer’s disease: a post-hoc analysis. Int J Geriatr Psychiatry 2001, 16(suppl):S71-S77.
Kaplan M: Atypical antipsychotics for treatment of mixed depression and anxiety. J Clin Psychiatry 2000, 61:388–389.
Weizman R, Weizman A: Use of atypical antipsychotics in mood disorders. Curr Opin Investig Drugs 2001, 2:940–945.
Scogin F, McElreath L: Efficacy of psychosocial treatments for geriatric depression: a quantitative review. J Cons Clin Psychol 1994, 62:69–74.
Barrowclough C, King P, Colville J, et al.: A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults. J Consult Clin Psychol 2001, 69:756–762. First controlled study to show efficacy of a psychotherapy for late-life anxiety (though the inclusion criteria were somewhat nonspecific in terms of anxiety symptoms or disorders).
Arean PA, Hegel MT, Reynolds CF: Treating depression in older medical patients with psychotherapy. J Geropsychol 2001, 7:93–104.
Alexopoulos GS, Katz I, Reynolds CF, et al.: Pharmacotherapy of depressive disorders in older patients. In Postgraduate Medicine Special Report. Edited by Roberts WO. Minneapolis: McGraw-Hill Companies; 2001:1–86. Expert consensus on treatment of late-life depression.
Mulsant BH, Alexopoulos GS, Reynolds CF, et al.: Pharmacologic treatment of depression in elderly primary care patients: the PROSPECT algorithm. Int J Geriatr Psychiatry 2001, 16:585–592.
Furukawa TA, Streiner DL, Young LT: Is antidepressantbenzodiazepine combination therapy clinically more useful? A meta-analytic study. J Affect Disord 2001, 65:173–177.
Buysse DJ, Reynolds CF, Houck PR, et al.: Does adjunctive lorazepam impair the antidepressant response to nortriptyline in elderly depressed patients? Sleep Res 1996, 25:153–158.
Leipzig RM, Cumming RG, Tinetti ME: Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999, 47:30–39.
Hanlon JT, Horner RD, Schmader KE, et al.: Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998, 64:684–692.
Zisselman MH, Rovner BW, Shmuely Y: Benzodiazepine use in the elderly prior to psychiatric hospitalization. Psychosomatics 1996, 37:38–42.
von Balkom AJ, Beekman AT, de Beurs E: Comorbidity of the anxiety disorders in a community-based older population in The Netherlands. Acta Psychiatr Scand 2000, 101:37–45.
Stahl SM, Mendels J, Schwartz GE: Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials. J Clin Psychopharmacol 2002, 22:388–392.
De Nayer A, Geerts S, Ruelens L, et al.: Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. Int J Neuropsychopharmacol 2002, 5:115–120.
Detke MK, Lu Y, Goldstein DJ, et al.: Duloxetine, 60mg once daily, for major depressive disorder: a randomized doubleblind placebo-controlled trial. J Clin Psychiatry 2002, 63:305–307.
Möller HJ: Rating depressed patients: observer vs selfassessment. Eur Psychiatry 2000, 15:160–172. Describes various benefits of self-report versus clinician rating for the evaluation of depression.
Dew MA, Reynolds CF, Houck PR, et al.: Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997, 54:1016–1024.
Mulsant BH, Reynolds CF, Shear MK, et al.: Comorbid anxiety disorders in late-life depression. Anxiety 1996, 2:242–247.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lenze, E.J. Comorbidity of depression and anxiety in the elderly. Curr Psychiatry Rep 5, 62–67 (2003). https://doi.org/10.1007/s11920-003-0011-7
Issue Date:
DOI: https://doi.org/10.1007/s11920-003-0011-7